Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Songqing Na

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2009
IRAK4 kinase activity is required for Th17 differentiation and Th17-mediated diseaseKirk A Staschke, Sucai Dong, Joy Saha, et al.
Arthritis Research & Therapy|August 4, 2019
Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulationsIain B McInnes, Nicole L Byers, Richard E Higgs, et al.
The Journal of Clinical Investigation|April 24, 2008
STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant miceMatthias Ernst, Meri Najdovska, Dianne Grail, et al.
Molecular Cancer Therapeutics|December 21, 2013
Characterization of LY2228820 dimesylate, a potent and selective inhibitor of p38 MAPK with antitumor activityRobert M Campbell, Bryan D Anderson, Nathan A Brooks, et al.
JCI Insight|July 10, 2023
A nondepleting anti-CD19 antibody impairs B cell function and inhibits autoimmune diseasesJeffrey S Boyles, Dorota Sadowski, Scott Potter, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2009
IRAK4 kinase activity is required for Th17 differentiation and Th17-mediated diseaseKirk A Staschke, Sucai Dong, Joy Saha, et al.
Arthritis Research & Therapy|August 4, 2019
Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulationsIain B McInnes, Nicole L Byers, Richard E Higgs, et al.
The Journal of Clinical Investigation|April 24, 2008
STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant miceMatthias Ernst, Meri Najdovska, Dianne Grail, et al.
Molecular Cancer Therapeutics|December 21, 2013
Characterization of LY2228820 dimesylate, a potent and selective inhibitor of p38 MAPK with antitumor activityRobert M Campbell, Bryan D Anderson, Nathan A Brooks, et al.
JCI Insight|July 10, 2023
A nondepleting anti-CD19 antibody impairs B cell function and inhibits autoimmune diseasesJeffrey S Boyles, Dorota Sadowski, Scott Potter, et al.
Pageof 3